UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 183

Sortiert nach

Spatially explicit regionalization of airborne flux measurements using environmental response functions

Biogeosciences, 2013-04, Vol.10 (4), p.2193-2217

2013

Volltextzugriff (PDF)

The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas

Oncogene, 2017-06, Vol.36 (22), p.3168-3177

2017

Volltextzugriff (PDF)

Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas

Neurology, 2009-10, Vol.73 (16), p.1273

2009

Volltextzugriff (PDF)

Vandetanib Successfully Controls Medullary Thyroid Cancer-Related Cushing Syndrome in an Adolescent Patient

The journal of clinical endocrinology and metabolism, 2014-09, Vol.99 (9), p.3055-3059

2014

Volltextzugriff (PDF)

Algebraic–coalgebraic recursion theory of history-dependent dynamical system models

Theoretical computer science, 2015-11, Vol.604, p.63-80

2015

Volltextzugriff (PDF)

Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a neurofibromatosis Clinical Trials Consortium phase II study

Neuro-oncology (Charlottesville, Va.), 2015-04, Vol.17 (4), p.596-603

2015

Volltextzugriff (PDF)

NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight

Neurology, 2007-02, Vol.68 (9), p.643

2007

Volltextzugriff (PDF)

Phase I trial of pegylated interferon-alpha-2b in young patients with plexiform neurofibromas

Neurology, 2011-01, Vol.76 (3), p.265

2011

Volltextzugriff (PDF)

Radiation Therapy in Management of Sporadic and Neurofibromatosis Type 1 (NF1) Associated Malignant Peripheral Nerve Sheath Tumors (MPNST)

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S638-S638

2012

Volltextzugriff (PDF)

Clinical Drug Development for Childhood Cancers

Clinical pharmacology and therapeutics, 2009-02, Vol.85 (2), p.127-129

2009

Volltextzugriff (PDF)

Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors : a report from the Children's Oncology Group

Cancer chemotherapy and pharmacology, 2006-09, Vol.58 (3), p.343-347

2006

Volltextzugriff (PDF)

Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas

Neuro-oncology (Charlottesville, Va.), 2014-05, Vol.16 (5), p.707-718

2014

Volltextzugriff (PDF)

Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101

Cancer chemotherapy and pharmacology, 2004-06, Vol.53 (6), p.482-488

2004

Volltextzugriff (PDF)

Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction

Journal of clinical oncology, 1997-05, Vol.15 (5), p.2125-2134

1997

Volltextzugriff (PDF)

Social-emotional functioning of children and adolescents with neurofibromatosis type 1 and plexiform neurofibromas: relationships with cognitive, disease, and environmental variables

Journal of pediatric psychology, 2012-08, Vol.37 (7), p.713-724

2012

Volltextzugriff (PDF)

Dihydrofolate Reductase Enzyme Inhibition Assay for Plasma Methotrexate Determination Using a 96-Well Microplate Reader

Clinical chemistry (Baltimore, Md.), 1999-02, Vol.45 (2), p.223-228

1999

Volltextzugriff (PDF)

Development and Validation of the English Pain Interference Index and Pain Interference Index‐Parent Report

Pain medicine (Malden, Mass.), 2015-02, Vol.16 (2), p.367-373

2015

Volltextzugriff (PDF)

Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acid

The Journal of pharmacology and experimental therapeutics, 2000-09, Vol.294 (3), p.894

2000

Volltextzugriff (PDF)

Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome

JAMA dermatology (Chicago, Ill.), 2023-10, Vol.159 (10), p.1112

2023

Volltextzugriff (PDF)

Phase I Trial and Pharmacokinetic Study of BMS-247550, an Epothilone B Analog, Administered Intravenously on a Daily Schedule for Five Days

Journal of clinical oncology, 2003-05, Vol.21 (9), p.1866-1873

2003

Volltextzugriff (PDF)

LB951 Establishing a roadmap for therapeutics development for cutaneous neurofibromas

Journal of investigative dermatology, 2017-10, Vol.137 (10), p.B4-B4

2017

Volltextzugriff (PDF)

Plasma pharmacokinetics and cerebrospinal fluid penetration of thioguanine in children with acute lymphoblastic leukemia : a collaborative Pediatric Oncology Branch, NCI, and Children's Cancer Group study

Cancer chemotherapy and pharmacology, 2001-03, Vol.47 (3), p.199-205

2001

Volltextzugriff (PDF)

Meeting Report: Pharmacology in Pediatric Oncology. Summary of the 10th International Expert Meeting of the Kind Philipp Foundation for Leukemia Research, June 10 - 13, 2001 at the Schloss Reisensburg, Günzburg an der Donau

Klinische Padiatrie, 2002-07, Vol.214 (4), p.236-239

2002

Volltextzugriff (PDF)

The plasma pharmacokinetics and cerebrospinal fluid penetration of the thymidylate synthase inhibitor raltitrexed (Tomudex) in a nonhuman primate model

Cancer chemotherapy and pharmacology, 1999, Vol.44 (6), p.439-443

1999

Volltextzugriff (PDF)

High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma: Incidence, treatment, and outcome

Cancer, 2004-05, Vol.100 (10), p.2222-2232

2004

Volltextzugriff (PDF)

1 – 25 von 183

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(170)
Mit Volltextzugriff
(163)

Publikationsform

Sprache

Englisch
(179)
Japanisch
(14)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(30)
Astronomy And Astrophysics
(22)
Scientific American
(10)
Cancer Chemotherapy And Pharmacology
(6)
Cancer
(5)
Nature
(4)
Neuro-Oncology
(4)
Pediatric Blood & Cancer
(4)
The Astronomical Journal
(4)
Cancer Research
(3)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Spatially explicit regionalization of airborne flux measurements using environmental response functions

The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas

Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas

Vandetanib Successfully Controls Medullary Thyroid Cancer-Related Cushing Syndrome in an Adolescent Patient

Algebraic–coalgebraic recursion theory of history-dependent dynamical system models

Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a neurofibromatosis Clinical Trials Consortium phase II study

NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight

Phase I trial of pegylated interferon-alpha-2b in young patients with plexiform neurofibromas

Radiation Therapy in Management of Sporadic and Neurofibromatosis Type 1 (NF1) Associated Malignant Peripheral Nerve Sheath Tumors (MPNST)

Clinical Drug Development for Childhood Cancers

Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors : a report from the Children's Oncology Group

Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas

Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101

Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction

Social-emotional functioning of children and adolescents with neurofibromatosis type 1 and plexiform neurofibromas: relationships with cognitive, disease, and environmental variables

Dihydrofolate Reductase Enzyme Inhibition Assay for Plasma Methotrexate Determination Using a 96-Well Microplate Reader

Development and Validation of the English Pain Interference Index and Pain Interference Index‐Parent Report

Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acid

Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome

Phase I Trial and Pharmacokinetic Study of BMS-247550, an Epothilone B Analog, Administered Intravenously on a Daily Schedule for Five Days

LB951 Establishing a roadmap for therapeutics development for cutaneous neurofibromas

Plasma pharmacokinetics and cerebrospinal fluid penetration of thioguanine in children with acute lymphoblastic leukemia : a collaborative Pediatric Oncology Branch, NCI, and Children's Cancer Group study

Meeting Report: Pharmacology in Pediatric Oncology. Summary of the 10th International Expert Meeting of the Kind Philipp Foundation for Leukemia Research, June 10 - 13, 2001 at the Schloss Reisensburg, Günzburg an der Donau

The plasma pharmacokinetics and cerebrospinal fluid penetration of the thymidylate synthase inhibitor raltitrexed (Tomudex) in a nonhuman primate model

High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma: Incidence, treatment, and outcome

Suchergebnisse filtern